S. A. Zakharchuk

S. A. Zakharchuk

Auto-generated profile, based on publicly available information

S. A. Zakharchuk

Lomonosov Moscow State University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2024 in Russian Cardiology Bulletin
Verified
Journal Article
Closed access
NMN.A. Mironov
N.A. Mironov
APAlexander V Priezzhev
Alexander V Priezzhev
Anastasia SveshnikovaAnastasia Sveshnikova
Anastasia Sveshnikova
ALA.E. Lugovtsov
A.E. Lugovtsov
NKN.A. Karanadze
N.A. Karanadze
IOIana Orlova
Iana Orlova
The study protocol was developed by the staff of the Lomonosov Moscow State University. This study is devoted to the association between blood rheology, hemostasis and functional status in patients with chronic heart failure (CHF). The importance of this study is determined by the need for new approaches to diagnosis and treatment of elderly patients with cardiovascular diseases, especially in context of widespread CHF in population. The study focuses on non-cardiac causes of impaired tolerance to physical exertion and importance of blood in binding and delivering oxygen. A unique feature of this research is modern optical technologies and artificial intelligence. Diagnostic methods include measuring the microrheological blood parameters at the level of cells and blood samples using modern optical methods and digital image processing. The study aims to explore the role of erythrocytes as an indicator of cardiovascular health. The authors pay a particular attention to red cell distribution width as a quantitative measure of anisocytosis and a complex indicator associated with various pathological processes in chronic diseases. The authors will investigate deformability and aggregation of erythrocytes, as well as their adhesion to vascular endothelium that is crucial for adequate perfusion and oxygen delivery to peripheral tissues.

28 December 2025 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
LKL.A. Kalashnikova
L.A. Kalashnikova
MDM.V. Dreval
M.V. Dreval
SZS.A. Zacharchuk
S.A. Zacharchuk
ASA.A. Shabalina
A.A. Shabalina
LDLarisa Dobrynina
Larisa Dobrynina
Objective. To study the features of cerebrovascular accidents (CVAs) in patients with primary vasculitis of the intracranial arteries (PVICA) and the change of contrast agent uptake by the vascular wall after treatment with corticosteroids. Material and methods. The study included 34 patients (19 males, 56%; mean age 41.4±8.8 years) with CVA associated with PVICA. All patients underwent MR angiography (MRA) of the intracranial arteries and a high-resolution MRI scan of the vascular wall before and after the contrast agent (CA) injection. Twenty-seven patients were treated with corticosteroids, and 25 of them were followed up. Results. Of the 34 study patients, 76% had CVA in the form of ischemic stroke (IS), which recurred in 29% of patients. Repeated transient CVAs (tCVAs) were reported in 82%. In 91% of cases, IS and tCVA occurred in the internal carotid artery (ICA) system. The National Institutes of Health Stroke Scale (NIHSS) showed mild or moderate IS in 96% of patients. MRA of the intracranial arteries revealed stenoses (56%), occlusions (12%), or their combination (32%). The CA uptake by the vascular wall was detected in all patients. After treatment with corticosteroids, 80% of 25 patients followed up for 29.1±28.7 months showed a clinical improvement. Repeated MRI of the vascular wall, performed in 16 patients within 21.1±26.3 months after treatment, showed the absence or decreased CA uptake in 4 patients, increased uptake in 2 patients, and no change in the uptake in 10 patients. Conclusion. CVAs in patients with PVICA usually occur as a minor stroke or repeated CVAs, and in 91% of cases, they involve the ICA system. Treatment with corticosteroids is effective in 80% of patients. The persistence of CA uptake by the vascular wall, as observed by MRI after treatment with clinical improvement, is likely due to post-inflammatory fibrosis.

21 February 2025 in Problems of Geroscience
Verified
Journal Article
Open access
PDF file
SZS. A. Zakharchuk
S. A. Zakharchuk
NMN. A. Mironov
N. A. Mironov
APA. G. Plisyuk
A. G. Plisyuk
IOIana Orlova
Iana Orlova
BACKGROUND. Global population aging leads to an increased rate of agerelated diseases such as arterial hypertension. Existing diagnostic methods are limited by the insufficient sensitivity of clinical and laboratory markers and the restrictions of conventional statistical methods. This highlights the need for new approaches to medical data analysis. This study is aimed to identify new laboratory markers of arterial hypertension using machine learning models and to compare their effectiveness compared with conventional methods. It involved the analysis of clinical and laboratory data of 2,228 patients over 65 years of age who sought medical advice at the clinic of the Medical Research and Educational Center of Lomonosov Moscow State University. Logistic regression with regularization, random forest, and gradient boosting were employed. Effectiveness was assessed using the AUC ROC, while attribute contributions were assessed by means of SHAP analysis. Machine learning models outperformed conventional logit regression. Gradient boosting achieved an AUC ROC of 0.85 compared to 0.78 for regression methods. The key attributes associated with arterial hypertension were age, RDW-SD value and creatinine levels, whereas conventional methods focused mainly on age. The conclusions confirm the high potential of machine learning methods in diagnosing age-related diseases. These models ensure higher accuracy and reveal complex interrelationships between indicators, which can improve early diagnosis and optimize diagnostic algorithms. Population aging is a global demographic trend leading to an increase in the incidence of agerelated diseases [1]. Early and accurate diagnosis of these conditions is becoming particularly important for effective treatment and minimization of the risk for complications in elderly patients. However, current diagnostic algorithms are often limited by the insufficient sensitivity and specificity of clinical and laboratory markers, while standard data analysis methods may not always detect hidden or nonlinear dependencies that are critical for diagnosis and prognosis assessment [2]. This necessitates the development of new approaches to interpretation of medical data and identification of more precise diagnostic criteria. Advances in machine learning (ML) and artificial intelligence (AI) offer new possibilities for the analysis of large and complex medical datasets. These methods allow uncovering complex and nonlinear relationships between various parameters, which can significantly enhance our understanding of pathogenesis, improve diagnostic accuracy, and increase the treatment effectiveness of age-related diseases in conditions of global population aging [3, 4].AIM. To identify new laboratory markers associated with arterial hypertension using ML models and to evaluate their effectiveness in comparison with conventional statistical methods.MATERIALS AND METHODS. A retrospective analysis was performed on a database containing clinical and laboratory indicators of 2,228 patients over 65 years of age who were affiliated with the Medical Research and Educational Center of Lomonosov Moscow State University and sought medical advice or underwent preventive examinations from 2020 to 2021. Data preprocessing included handling of missing values, dealing with outliers, and normalization of attributes. In this pilot study conducted to refine the analytical tools, the presence of arterial hypertension was considered the target variable. Binary logistic regression, a standard and widely accepted method for identification of disease markers, as well as ML models such as logistic regression with regularization, a random forest model, and gradient boosting were employed. The performance of these methods was assessed using the area under the ROC curve (AUC ROC). The contribution of each attribute was interpreted using the SHAP analysis.RESULTS. The ML models have been proven to be superior compared with conventional logistic regression. Gradient boosting achieved an AUC ROC of 0.85, whereas logistic regression showed an AUC ROC of 0.78 (Fig. 1). The most important attributes associated with the presence of arterial hypertension were age, red blood cell distribution width (RDW-SD), and creatinine levels. Meanwhile, the standard regression analysis relied primarily on age (Fig. 2, 3). Age and creatinine levels were expectedly significant factors, while RDW-SD, typically evaluated in the context of anemia and associated with erythropoiesis, was also identified as a significant marker of arterial hypertension. These findings may indicate a broader relationship between inflammatory processes and the state of erythropoiesis with the development of arterial hypertension.CONCLUSIONS. Our findings reveal the high potential of ML models in medical diagnostics for identification of new laboratory markers of age-related diseases. ML methods not only provide higher predictive accuracy but also uncover complex, previously unknown relationships between clinical and laboratory indicators and the onset and progression of diseases. Unlike conventional statistical methods, they account for nonlinear and multidimensional interactions between features. These findings can serve as a basis for further clinical research aimed at confirming the associations found and developing new targets for intervention, potentially leading to changes in diagnostic and treatment approaches. Implementation of these models in clinical practice may improve early diagnosis of age-related diseases, reduce morbidity and mortality, and ultimately enhance patient quality of life.

5 March 2026 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
LKL.A. Kalashnikova
L.A. Kalashnikova
ASA.A. Shabalina
A.A. Shabalina
MDM.V. Dreval
M.V. Dreval
SZS.A. Zacharchuk
S.A. Zacharchuk
LDLarisa Dobrynina
Larisa Dobrynina
Objective. To investigate the presence of antibodies to herpes viruses (Varicella zoster virus [VZV], herpes simplex virus types I and II, Epstein-Barr virus, and cytomegalovirus) and their DNA in the cerebrospinal fluid (CSF) of patients with a history of ischemic stroke (IS) and/or transient cerebrovascular accident (TIA) caused by primary cerebral vasculitis (PCV); to evaluate their clinical significance. Material and methods. Thirty-one patients (mean age 41.2±8.7 years, 18 males, 58%) with PCV and a history of IS and/or transient cerebrovascular accidents (TIA), which in 94% occurred in the internal carotid artery (ICA) system, were examined. Antibodies were tested by enzyme-linked immunosorbent assay (ELISA) or immunochemiluminescence, and herpesvirus DNA was tested by polymerase chain reaction (PCR). Results. An increase in immunoglobulin (Ig) G antibodies to the VZV virus (anti-VZV IgG antibodies) was detected in 10 (32%) of 31 patients in the CSF; one of them also had Ig antibodies to the herpes simplex virus. There were statistically significant differences between patients with and without anti-VZV IgG antibodies regarding the frequency of convulsive disorder (40% vs. 0%, respectively, p=0.0023), TIA (60% vs. 90%, respectively, p=0.0483), the insidious onset of stroke symptoms (over several hours to 2—3 days) (30% vs. 0%, respectively, p=0.0092) and the increase in the erythrocyte sedimentation rate [ESR] (0% vs. 33%, respectively, p=0.0412). Conclusion. An increase in anti-VZV IgG antibodies in CSF in 32% of patients suggests VZV activation in the trigeminal ganglion and its transaxonal spread along the branches of the trigeminal nerve into the walls of the ICA and the middle and anterior cerebral arteries, where VZV causes inflammation. It explains the most common lesion of the ICA system (94%), its locality, and the absence of systemic inflammatory signs. In patients without anti-VZV IgG antibodies, it is assumed that PCV is caused by other neurotropic pathogens that can affect hemostasis.

30 December 2025 in Russian Cardiology Bulletin
Verified
Journal Article
Closed access
PDF file
NMN.A. Mironov
N.A. Mironov
TKT.N. Krasnova
T.N. Krasnova
LDL.I. Dyachuk
L.I. Dyachuk
MUM.B. Usherzon
M.B. Usherzon
SZS.A. Zakharchuk
S.A. Zakharchuk
SMSimon Matskeplishvili
Simon Matskeplishvili
The clinical trial No. REFRANGINA-TRIAL protocol is aimed at dynamic assessment of myocardial perfusion and contractility in patients with refractory angina under combined intermittent hypo-hyperoxic therapy. Refractory angina characterized by persistent symptoms and impaired functional status despite optimal medical treatment, as well as ineffective invasive revascularization affects 5—10% of patients with coronary artery disease. The study will enroll 60 patients with coronary artery disease and refractory angina class II—III confirmed by stress tests. Patients will be randomized into three groups: group 1 — combined therapy (10 sessions of intermittent hypo-hyperoxic therapy over 2 weeks and 5-week medical therapy beginning 3 weeks prior to hypo-hyperoxic sessions); group 2 — a course of hypo-hyperoxic therapy with placebo (10 sessions over 2 weeks); group 3 — standard treatment according to current protocol. Treatment efficacy will be evaluated using contrast-enhanced perfusion MRI, echocardiography (with measurement of ejection fraction and global longitudinal strain of the left ventricle), stress tests (treadmill test and 6-minute walk test), as well as assessment of endothelial function by NICaS method and quality of life (SF-36 questionnaire). Treatment safety will be monitored through regular checks of vital signs, ECGs, laboratory tests, and physical examinations, along with recording of adverse events. The study is conducted in strict accordance with the Declaration of Helsinki, legislation of the Russian Federation, and Good Clinical Practice standards (ICH-GCP). It is anticipated that final results will confirm safety and efficacy of this new non-invasive approach for treating refractory angina. This will optimize therapeutic strategies and update clinical guidelines in the Russian Federation.

27 September 2026 in South Russian Journal of Therapeutic Practice
Verified
Journal Article
Open access
PDF file
SZS. A. Zakharchuk
S. A. Zakharchuk
NMN. A. Mironov
N. A. Mironov
APA. G. Plisyuk
A. G. Plisyuk
IOIana Orlova
Iana Orlova
СЗС. А. Захарчук
С. А. Захарчук
ЯОЯ. А. Орлова
Я. А. Орлова
Objective: development and evaluation of a machine learning model for predicting arterial hypertension using demographic characteristics and complete blood count parameters, and to assess the contribution of key predictors using interpretable methods. Materials and methods: we analyzed a dataset of 5,506 patients examined at the University Clinic of the Medical Research and Educational Institute of Lomonosov Moscow State University in 2021–2022 (2,256 men and 3,250 women, mean age 57.23±17.60 years). Arterial hypertension was identified in 3,697 (67%) individuals, while 1,809 (33%) formed the nonhypertensive group. Variables included sex, age, complete blood count parameters, and derived inflammatory indices (NLR, LMR, PLR). The proposed stacking model was compared with Lasso and Ridge regression, logistic regression, random forest, and gradient boosting. Model performance was assessed using the AUC. Results: AUC ranged from 0.75 to 0.77 for classic machine learning models, whereas the stacking model achieved an AUC of 0.99. The difference in AUC between the stacking model and alternative approaches was statistically significant (p<0.001), with a mean improvement of 22.9% compared with logistic regression. The leading markers were age and the erythrocyte indices RDW-SD, MCV, HGB, and MCH. Conclusion: based on internal validation, ensemble machine learning methods incorporating complete blood count parameters may improve the discriminative performance of cardiovascular risk prediction models; however, these performance estimates require confirmation through external validation in an independent cohort. Age and erythrocyte indices (RDW-SD, MCV, HGB, MCH) were the most informative predictors of arterial hypertension and may serve as accessible marker candidates for further research and improved risk stratification.